Literature DB >> 12216046

Tap water for irrigation of lacerations.

Beatrix Chandra Bansal1, Robert A Wiebe, Sebrina D Perkins, Thomas J Abramo.   

Abstract

This study was designed to compare the infection rates of simple lacerations irrigated with tap water versus sterile normal saline before repair. Patients with simple lacerations to an extremity that were less than 8 hours from injury were prospectively enrolled. Exclusions from the study were: dog bites, hand lacerations, immunocompromised patients, and those on antibiotics at the time of injury. Patients who qualified were randomized to receive tap water or normal saline for wound irrigation. Before and after irrigation, wound cultures were obtained. After the procedure was complete, patients were scheduled for a 48 hour follow-up wound check. A total of 46 patients were enrolled in the study. Twenty-four patients were randomized to the normal saline group and 21 were assigned to receive tap water irrigation. There were 2 infected lacerations in both the tap water and normal saline groups. The organisms cultured from the wounds in both groups were similar and there was no difference in colony counts when tap water was used. The use of tap water for the irrigation of lacerations does not result in the growth of unusual organisms or increase the colony counts of organisms. Wound infection rates were the same in both groups. This pilot study suggests that the use of tap water for irrigation of wounds may be safe. Further validation is necessary. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12216046     DOI: 10.1053/ajem.2002.35501

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  15 in total

1.  Postoperative care of the facial laceration.

Authors:  Nicholas Medel; Neeraj Panchal; Edward Ellis
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2010-12

2.  Irrigating methicillin-resistant Staphylococcus aureus-colonised and -infected chronic wounds with tap water.

Authors:  Tzong-Shiun Li; Mun-Yau Choong; Shu-Fu Wu; Kai-Jung Chen
Journal:  Int Wound J       Date:  2012-03-08       Impact factor: 3.315

3.  Cleansing of wounds by tap water? Would it be safe to use in developing countries?

Authors:  Basavraj S Nagoba; Namdev M Suryawanshi; Sohan P Selkar
Journal:  Int Wound J       Date:  2015-09-24       Impact factor: 3.315

Review 4.  Diabetic foot infections: stepwise medical and surgical management.

Authors:  David G Armstrong; Benjamin A Lipsky
Journal:  Int Wound J       Date:  2004-06       Impact factor: 3.315

5.  Irrigating methicillin-resistant Staphylococcus aureus-colonised and -infected chronic wounds - why use tap water?

Authors:  Basavraj S Nagoba; Sohan P Selkar; Jitendra B Mule
Journal:  Int Wound J       Date:  2013-09-19       Impact factor: 3.315

6.  Cleansing of wounds by tap water? An evidence-based systemic analysis.

Authors:  Chia-Yu Huang; Mun-Yau Choong; Tzong-Shiun Li
Journal:  Int Wound J       Date:  2013-06-27       Impact factor: 3.315

Review 7.  Comparison of wounds' infection rate between tap water and normal saline cleansing: A meta-analysis of randomised control trials.

Authors:  Chia-Yu Huang; Mun-Yau Choong
Journal:  Int Wound J       Date:  2018-09-06       Impact factor: 3.315

Review 8.  National Athletic Trainers' Association Position Statement: Management of Acute Skin Trauma.

Authors:  Joel W Beam; Bernadette Buckley; William R Holcomb; Mario Ciocca
Journal:  J Athl Train       Date:  2017-01-16       Impact factor: 2.860

9.  Randomized controlled trial of prophylactic antibiotics for dog bites with refined cost model.

Authors:  James V Quinn; Daniel McDermott; Jennifer Rossi; John Stein; Nathan Kramer
Journal:  West J Emerg Med       Date:  2010-12

10.  Traumatic lacerations: what are the risks for infection and has the 'golden period' of laceration care disappeared?

Authors:  James V Quinn; Steven K Polevoi; Michael A Kohn
Journal:  Emerg Med J       Date:  2013-01-12       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.